STEQEYMA
NDC 72606-029, ustekinumab-stba, injection, solution, from CELLTRION USA, Inc..
- Product NDC
- 72606-029
- Status
- Listed
- Labeler
- CELLTRION USA, Inc.
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761338
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/72606-029 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- USTEKINUMAB130 mg/26mL
Pharmacologic classes
Interleukin-12 Antagonist [EPC]; Interleukin-12 Antagonists [MoA]; Interleukin-23 Antagonist [EPC]; Interleukin-23 Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 72606-029-01 | 72606002901 | 1 VIAL, SINGLE-USE in 1 CARTON (72606-029-01) / 26 mL in 1 VIAL, SINGLE-USE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/66085e17-e3f2-4196-8c81-87448e804b0cMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=72606-029
Use it
Look up 72606-029 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/72606-029 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 72606-029. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.